Honari J, Blair A D, Cutler R E
Clin Pharmacol Ther. 1977 Oct;22(4):395-401. doi: 10.1002/cpt1977224395.
Furosemide kinetics were studied in 4 normal subjects after single intravenous injections (1 mg/kg). One experiment was done after pretreatment with probenecid. The apparent volume of furosemide distribution was unchanged after probenecid (10.9 L). The mean plasma clearance fell from 155 to 85 ml/min and the mean plasma t1/2 rose from 36 to 61 min. Renal clearance of furosemide fell below 50% of control after probenecid, but the kidney remained the main route of its excretion (75% of the dose appeared in the urine). In another experiment in 4 subjects an infusion of furosemide was sustained following a loading dose to maintain a constant plasma level. After a control period, probenecid was given orally. This resulted in a decrease in renal excretion of furosemide with a simultaneous rise in its plasma concentration. Despite the rising plasma furosemide concentration, however, there was a diminution in both urine flow and the excreted fraction of filtered sodium, which suggested some reduction of diuretic action. In doses commonly used, probenecid reduces renal elimination of furosemide in man with only a mild impairment of its diuretic activity. This suggests that furosemide is eliminated predominantly by way of proximal tubular secretion and that tubular rather than plasma concentration is the main determinant of its diuretic effect.
对4名正常受试者单次静脉注射(1毫克/千克)速尿后研究其动力学。在丙磺舒预处理后进行了一项实验。丙磺舒处理后,速尿的表观分布容积未变(10.9升)。平均血浆清除率从155毫升/分钟降至85毫升/分钟,平均血浆半衰期从36分钟升至61分钟。丙磺舒处理后,速尿的肾清除率降至对照值的50%以下,但肾脏仍是其主要排泄途径(75%的剂量出现在尿液中)。在另一项针对4名受试者的实验中,在给予负荷剂量后持续输注速尿以维持恒定的血浆水平。在对照期后,口服丙磺舒。这导致速尿的肾排泄减少,同时其血浆浓度升高。然而,尽管血浆速尿浓度升高,但尿流量和滤过钠的排泄分数均降低,这表明利尿作用有所减弱。在常用剂量下,丙磺舒减少人体对速尿的肾清除,但其利尿活性仅有轻度受损。这表明速尿主要通过近端小管分泌消除,且小管浓度而非血浆浓度是其利尿作用的主要决定因素。